A lung-on-chip in vitro approach to study inflammation at the alveolar level

N. Roldan (Bern, Switzerland), A. Rapet (Bern, Switzerland), G. Raggi (Bern, Switzerland), M. Epars (Bern, Switzerland), K. Fytianos (Bern, Switzerland), J. Stucki (Bern, Switzerland), N. Schneider-Daum ( Saarbrücken, Germany), C. Michael-Lehr ( Saarbrücken, Germany), H. Huwer ( Völklingen, Germany), T. Geiser (Bern, Switzerland), O. Guenat (Bern, Switzerland), N. Hobi (Bern, Switzerland)

Source: International Congress 2019 – Understanding lung disease: novel in vitro models
Session: Understanding lung disease: novel in vitro models
Session type: Oral Presentation
Number: 1903

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Roldan (Bern, Switzerland), A. Rapet (Bern, Switzerland), G. Raggi (Bern, Switzerland), M. Epars (Bern, Switzerland), K. Fytianos (Bern, Switzerland), J. Stucki (Bern, Switzerland), N. Schneider-Daum ( Saarbrücken, Germany), C. Michael-Lehr ( Saarbrücken, Germany), H. Huwer ( Völklingen, Germany), T. Geiser (Bern, Switzerland), O. Guenat (Bern, Switzerland), N. Hobi (Bern, Switzerland). A lung-on-chip in vitro approach to study inflammation at the alveolar level. 1903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017



B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


In vitro, in silico and in vivo study challenges the impact of bronchial thermoplasty on acute airway smooth muscle mass loss
Source: Eur Respir J, 51 (5) 1701680; 10.1183/13993003.01680-2017
Year: 2018



Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005


The effect of tenascin-c deficiency on TGF-β-mediated fibrosis and alveolar inflammation in a murine model of ARDS
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017

Effect of human neutrophil proteases on ex vivo small airway function
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013

Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018

The effect of mast cell stabilisation in a large animal model of pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019


An expanding protocol to validate nasospheroids as a functional assay to study airway CFTR-fluid transport
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020


Oxidative activity of alveolar macrophages in COPD (clinical and experimental conformity)
Source: Eur Respir J 2002; 20: Suppl. 38, 519s
Year: 2002

In vitro study of the inflammatory response, mediated by interleukin-8, in mesothelial cells stimulated with doxycycline
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007

Aerobic training decreases epithelial expression of Th2 cytokines in a murine model of allergic lung inflammation
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models
Year: 2007


Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


Validation of a macrophage specific cell line for the development of an in vitro lower airways co-culture model
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


Novel protective role of alveolar macrophages in adaptation to lung injury.
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Immunocytochemical study of cytokines production in site of inflammation during interleukin-1β local treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 314s
Year: 2002

Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Modeling alveolar barrier disruption in vitro for sepsis-induced ARDS preclinical studies
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020